M&A Deal Summary |
|
---|---|
Date | 2015-04-28 |
Target | RX Global Capital |
Sector | Medical Products |
Buyer(s) | Callitas Therapeutics |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2003 |
Sector | Healthcare Services |
Revenue | 1M CAD (2017) |
Callitas Health is focuses on providing biomedical technologies that improve the health and quality of life for people affected by obesity and diabetes. Callitas Health was founded in 2003 and is based in Vancouver, Canada.
DEAL STATS | # |
---|---|
Overall | 2 of 4 |
Sector (Medical Products) | 2 of 2 |
Type (Add-on Acquisition) | 2 of 3 |
State (British Columbia) | 1 of 1 |
Country (Canada) | 2 of 2 |
Year (2015) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-02-19 |
M Diagnostics
Calgary, Alberta, Canada M Diagnostics, Inc. is a manufacturer of eMosquito monitoring devices to measure blood glucose, primarily by diabetics. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-06-01 |
Chelatexx - Reformulated Orlistat For Weight Loss
United States Chelatexx - Reformulated Orlistat For Weight Loss comprises a weight loss pharmaceutical product. The asset is located in the United States. |
Buy | - |